161 related articles for article (PubMed ID: 6208038)
41. Resistance to Trypanosoma cruzi infection in mice does not necessarily correlate with production of interferon-gamma in vivo.
Meyer zum Büschenfelde C; Cramer S; Fleischer B; Frosch S
Med Microbiol Immunol; 1998 Oct; 187(2):107-13. PubMed ID: 9832325
[TBL] [Abstract][Full Text] [Related]
42. Activation by synergism between endotoxin and lymphokines of the mouse macrophage cell line J774 against infection by Trypanosoma cruzi.
Alcina A; Fresno M
Parasite Immunol; 1987 Mar; 9(2):175-86. PubMed ID: 3106922
[TBL] [Abstract][Full Text] [Related]
43. Trypanosoma cruzi: modulation of parasite-cell interaction by plasma fibronectin.
Ouaissi MA; Cornette J; Capron A
Eur J Immunol; 1985 Nov; 15(11):1096-101. PubMed ID: 2933263
[TBL] [Abstract][Full Text] [Related]
44. Production of MMP-9 and inflammatory cytokines by Trypanosoma cruzi-infected macrophages.
de Pinho RT; da Silva WS; de Castro Côrtes LM; da Silva Vasconcelos Sousa P; de Araujo Soares RO; Alves CR
Exp Parasitol; 2014 Dec; 147():72-80. PubMed ID: 25448360
[TBL] [Abstract][Full Text] [Related]
45. Selection of TcII Trypanosoma cruzi population following macrophage infection.
Pena DA; Eger I; Nogueira L; Heck N; Menin Á; Báfica A; Steindel M
J Infect Dis; 2011 Aug; 204(3):478-86. PubMed ID: 21742848
[TBL] [Abstract][Full Text] [Related]
46. Trypanosoma cruzi: T-cell-dependent mechanisms of resistance during chronic infection.
Rottenberg ME; Cardoni RL; Sinagra A; Riarte A; Rodriguez Nantes I; Lauricella M; Segura EL
Exp Parasitol; 1991 Aug; 73(2):127-36. PubMed ID: 1909649
[TBL] [Abstract][Full Text] [Related]
47. CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation.
Chaussabel D; Jacobs F; de Jonge J; de Veerman M; Carlier Y; Thielemans K; Goldman M; Vray B
Infect Immun; 1999 Apr; 67(4):1929-34. PubMed ID: 10085038
[TBL] [Abstract][Full Text] [Related]
48. Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection.
Chamekh M; Vercruysse V; Habib M; Lorent M; Goldman M; Allaoui A; Vray B
Infect Immun; 2005 Oct; 73(10):6552-61. PubMed ID: 16177330
[TBL] [Abstract][Full Text] [Related]
49. Protection of young rats from acute Trypanosoma cruzi infection by interferon-gamma given to their mothers during pregnancy.
Davila HO; Revelli SS; Didoli G; Bernabo J; Wietzerbin J; Falcoff E; Bottasso OA
Am J Trop Med Hyg; 1996 Jun; 54(6):660-4. PubMed ID: 8686789
[TBL] [Abstract][Full Text] [Related]
50. Age-related increase in resistance to acute Trypanosoma cruzi infection in rats is associated with an appropriate antibody response.
Pascutti MF; Bottasso OA; Hourquescos MC; Wietzerbin J; Revelli S
Scand J Immunol; 2003 Aug; 58(2):173-9. PubMed ID: 12869138
[TBL] [Abstract][Full Text] [Related]
51. Monoclonal antibodies mediating viable immunofluorescence and protection against Trypanosoma cruzi infection.
Heath AW; Martins MS; Hudson L
Trop Med Parasitol; 1990 Dec; 41(4):425-8. PubMed ID: 2127473
[TBL] [Abstract][Full Text] [Related]
52. Effect of anti-gamma-interferon and anti-interleukin-4 administration on the resistance of mice against infection with reticulotropic and myotropic strains of Trypanosoma cruzi.
Petray PB; Rottenberg ME; Bertot G; Corral RS; Diaz A; Orn A; Grinstein S
Immunol Lett; 1993 Jan; 35(1):77-80. PubMed ID: 8458639
[TBL] [Abstract][Full Text] [Related]
53. Trypanosoma cruzi-induced decrease in the level of interferon-gamma receptor expression by resting and activated human blood lymphocytes.
Kierszenbaum F; Mejia Lopez H; Tanner MK; Sztein MB
Parasite Immunol; 1995 Apr; 17(4):207-14. PubMed ID: 7624161
[TBL] [Abstract][Full Text] [Related]
54. Type I interferons increase host susceptibility to Trypanosoma cruzi infection.
Chessler AD; Caradonna KL; Da'dara A; Burleigh BA
Infect Immun; 2011 May; 79(5):2112-9. PubMed ID: 21402764
[TBL] [Abstract][Full Text] [Related]
55. Trypanosoma cruzi: isolate dependence in the induction of lytic antibodies in the mouse and rabbit.
Muller LA; Añasco N; González Cappa SM
Exp Parasitol; 1986 Jun; 61(3):284-93. PubMed ID: 3086113
[TBL] [Abstract][Full Text] [Related]
56. Characterization of Trypanosoma cruzi infectivity, proliferation, and cytokine patterns in gut and pancreatic epithelial cells maintained in vitro.
Martello LA; Wadgaonkar R; Gupta R; Machado FS; Walsh MG; Mascareno E; Tanowitz HB; Haseeb MA
Parasitol Res; 2013 Dec; 112(12):4177-83. PubMed ID: 24018709
[TBL] [Abstract][Full Text] [Related]
57. Acute and chronic experimental Trypanosoma cruzi infection in the rat. Response to systemic treatment with recombinant rat interferon-gamma.
Revelli S; Davila H; Ferro ME; Romero-Piffiguer M; Musso O; Valenti J; Bernabo J; Falcoff E; Wietzerbin J; Bottasso O
Microbiol Immunol; 1995; 39(4):275-81. PubMed ID: 7651241
[TBL] [Abstract][Full Text] [Related]
58. Endogenous interferon-gamma, macrophage activation, and murine host defense against acute infection with Trypanosoma cruzi.
McCabe RE; Meagher SG; Mullins BT
J Infect Dis; 1991 Apr; 163(4):912-5. PubMed ID: 1901337
[TBL] [Abstract][Full Text] [Related]
59. Enhanced protection by melatonin and meloxicam combination in experimental infection by Trypanosoma cruzi.
Oliveira LG; Kuehn CC; Santos CD; Toldo MP; do Prado JC
Parasite Immunol; 2010 Apr; 32(4):245-51. PubMed ID: 20398224
[TBL] [Abstract][Full Text] [Related]
60. Changes in cell populations and immunoglobulin-producing cells in the spleens of mice infected with Trypanosoma cruzi: correlations with parasite-specific antibody response.
Tarleton RL; Kuhn RE
Cell Immunol; 1983 Sep; 80(2):392-404. PubMed ID: 6411359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
